We are live on ! Find out more
DZ Bank

DZ Bank Portfolio holdings

AUM $113B
1-Year Est. Return 36.92%
This Fund
S&P 500
This Quarter Est. Return
+0.59%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
AUM
$25.8B
AUM Growth
-$269M
Cap. Flow
-$283M
Cap. Flow %
-1.1%
Top 10 Hldgs %
18.42%
Holding
1,201
New
375
Increased
315
Reduced
232
Closed
63

Top Buys

Rank Stock Value
1
USB icon
US Bancorp
USB
+$195M
2
EA icon
Electronic Arts
EA
+$160M
3
PYPL icon
PayPal
PYPL
+$134M
4
HPE icon
Hewlett Packard
HPE
+$88.3M
5
MDLZ icon
Mondelez International
MDLZ
+$84.8M

Sector Composition

Rank Sector Weight
1 Financials 22%
2 Technology 14.64%
3 Healthcare 13.55%
4 Consumer Discretionary 9.87%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARLZ
726
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$425K ﹤0.01%
+283,235
New +$494K
VMI icon
727
Valmont Industries
VMI
$9.33B
$424K ﹤0.01%
+2,900
New +$453K
TTPH
728
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$424K ﹤0.01%
+6,910
New +$607K
PFPT
729
DELISTED
Proofpoint, Inc.
PFPT
$422K ﹤0.01%
+3,715
New +$394K
CYTK icon
730
Cytokinetics
CYTK
$10.8B
$418K ﹤0.01%
+58,000
New +$497K
FTNT icon
731
Fortinet
FTNT
$110B
$418K ﹤0.01%
+38,895
New +$379K
WNC icon
732
Wabash National
WNC
$541M
$412K ﹤0.01%
19,817
-5,377
-21% -$121K
RNAC icon
733
Cartesian Therapeutics
RNAC
$225M
$409K ﹤0.01%
+1,338
New +$381K
EQIX icon
734
Equinix
EQIX
$102B
$405K ﹤0.01%
968
+750
+344% +$316K
AKAO
735
DELISTED
Achaogen Inc
AKAO
$403K ﹤0.01%
+31,122
New +$353K
CRVS icon
736
Corvus Pharmaceuticals
CRVS
$1.12B
$402K ﹤0.01%
+34,858
New +$330K
SNY icon
737
Sanofi
SNY
$109B
$401K ﹤0.01%
+10,000
New +$416K
HDB icon
738
HDFC Bank
HDB
$121B
$395K ﹤0.01%
+16,000
New +$403K
RGNX icon
739
Regenxbio
RGNX
$615M
$387K ﹤0.01%
+12,978
New +$378K
GDOT icon
740
Green Dot
GDOT
$758M
$386K ﹤0.01%
+6,013
New +$379K
ANAB icon
741
AnaptysBio
ANAB
$1.54B
$385K ﹤0.01%
+3,698
New +$417K
KALV
742
DELISTED
KalVista Pharmaceuticals
KALV
$385K ﹤0.01%
+40,636
New +$425K
STML
743
DELISTED
Stemline Therapeutics, Inc.
STML
$382K ﹤0.01%
+24,954
New +$389K
CMA
744
DELISTED
Comerica
CMA
$381K ﹤0.01%
+3,962
New +$378K
RGA icon
745
Reinsurance Group of America
RGA
$15.9B
$378K ﹤0.01%
+2,458
New +$386K
SHW icon
746
Sherwin-Williams
SHW
$87.4B
$373K ﹤0.01%
+2,850
New +$389K
BHC icon
747
Bausch Health
BHC
$1.69B
$369K ﹤0.01%
+23,173
New +$431K
JKS
748
JinkoSolar
JKS
$782M
$365K ﹤0.01%
20,000
PGR icon
749
Progressive
PGR
$128B
$365K ﹤0.01%
+5,998
New +$342K
HRTX icon
750
Heron Therapeutics
HRTX
$92M
$361K ﹤0.01%
+13,062
New +$296K

Similar funds

DZ Bank's Q1 2018 Portfolio in Review

As of Q1 2018, DZ Bank held 1,201 positions worth $25.8B, down 1% from $26.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

DZ Bank's Q1 2018 filing shows 375 new, 315 increased, 232 reduced and 63 closed positions. Its largest new stake was Nutrien: 1,618,945 shares worth $69.2M. The largest sale was Comcast, an estimated $180M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

  • DZ Bank's largest Q1 2018 buy was Nutrien: 1,618,945 shares worth $69.2M.
  • DZ Bank added most to US Bancorp in Q1 2018, an estimated $195M increase.
  • DZ Bank's biggest Q1 2018 reduction was Comcast, cutting an estimated $180M.
  • DZ Bank fully exited Macquarie Infrastructure Holdings, LLC in Q1 2018, selling an estimated $3.6M.
  • DZ Bank's ten largest holdings make up 18% of its $25.8B portfolio in Q1 2018.
  • DZ Bank opened 375 new positions and closed 63 in Q1 2018.
  • DZ Bank's portfolio value fell 1% quarter-over-quarter to $25.8B.

Based on DZ Bank's 13F filing for Q1 2018, filed 15 May 2018.